跳至主要内容
临床试验/EUCTR2016-003557-15-GB
EUCTR2016-003557-15-GB进行中(未招募)1 期

A Study to Investigate the Effect of ß-Hydroxy-ß-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness. - HMB-IC

Guy's and St Thomas NHS Foundation Trust0 个研究点目标入组 68 人开始时间: 2017年10月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria are
  • (i) =18 years old
  • (ii) Due to receive enteral nutrition via a nasogastric or naso-jejunal tube as part of routine care
  • (iii) Receiving mechanical ventilation and likely to continue this for more than 48 hours
  • (iv) Likely to remain on the ICU for >7 days
  • (v) Likely to survive intensive care admission.
  • (vi) Admitted to recruiting ICU <24 hours from hospital admission and referring ICU ? 7 days from hospital admission
  • (vii) Agreement obtained from legal representative
  • (viii) Able to comply with protocol and study procedures
  • (ix) No known allergy to IMP or any of its excipients
  • Participants in other trials can be recruited where protocols are not deemed likely to interfere with endpoints of either study and agreement has been obtained from the respective Chief Investigators.
  • Since participants in the trial will be abstaining by virtue of their illness, contraception is not required as an eligibility requirement.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 68
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 68

排除标准

  • (i) Pregnancy or breast feeding
  • (ii) Active disseminated malignancy (diagnosed)
  • (iii) Bilateral lower limb amputees
  • (iv) Non-ambulant or acute unilateral lower limb amputees
  • (v) Patients with a primary neuromyopathy
  • (vi) Patients entered into trials of interventions which would affect muscle mass
  • (vii) Patients assessed as requiring sole parenteral nutrition
  • (viii) Admission to ICU within the previous 3 months
  • (ix) Any reason excluding ultrasound measurement being performed
  • (ix) Insufficient understanding of the trial by the legal representative
  • (xi) Intolerance to lactose and/or milk protein allergy

研究者

相似试验